How are hospitals bracing for tariffs?

The latest stories trending on MedCity News.

Editor's Pick

Top Story How Are Hospitals Bracing for Tariffs? The Trump administration's steep tariffs on Chinese imports are threatening to further destabilize hospitals' bottom lines by driving up the cost of essential supplies and exacerbating already fragile supply chains. As providers prepare for higher expenses and potential shortages, experts warn that these policies could worsen care quality and force hospitals to make tough financial decisions — from cutting services to delaying tech upgrades. Sponsored How To Make It Easier For Early Stage Life Science Companies to Grow Presented by Mercury and MedCity News A webinar on May 8th, sponsored by fintech business Mercury will explore how a banking platform approach could be a resource for the needs of entrepreneurs across biotech, diagnostics, and other life science companies. Sign up to learn more!

Featured News

What Are Health Systems' Strategic Priorities in 2025? The healthcare investor conference MedCity INVEST, scheduled for May 20-21 at the Willis Tower in Chicago, will spotlight a wide range of topics from GLP-1 drug coverage to investment trends and more. Register today! Blockbuster Sanofi & Regeneron Drug Dupixent Notches FDA Nod for an Inflammatory Skin Disease The FDA approved Sanofi and Regeneron Pharmaceuticals drug Dupixent as a treatment for the inflammatory skin disorder chronic spontaneous urticaria. The regulatory decision comes two years after the agency turned down an application for the biologic drug in this indication. Women's Health is Having Its Moment – It's Time for the System to Catch Up Too many women have experienced the impacts of living with gynecological conditions while feeling dismissed and struggling to get care. Women deserve better, and as we collectively challenge outdated norms, we are beginning to see improvement. Still, there's much more work to be done. Drug-Gene Testing: Key to Safer Cancer Treatment Although the healthcare industry has a long way to go before PGx testing for DPYD and other genes becomes widespread, it's encouraging that regulatory bodies and professional organizations are making recommendations and raising awareness among healthcare providers. Why UnitedHealth Group's Shares Have Taken a Tumble UnitedHealth Group's shares fell by over 22% on Thursday after its first quarter earnings. This is largely due to challenges in its Medicare Advantage business.

Video   Vaccine Makers Aren't Speaking Out Against RFK Jr. Earlier this year at the annual J.P. Morgan healthcare conference in San Francisco, Pfizer CEO Albert Bourla said his company would be at the vanguard fighting in favor of vaccines if Robert F. Kennedy Jr. took action against these treatments. Since then, the Texas measles outbreak has spread — and Kennedy has failed to encourage vaccines, instead stressing that they should be optional. Additionally, Peter Marks, the former head of the FDA's Center for Biologics Evaluation and Research, resigned this month, and he has gone on the record saying that vaccine misinformation reigns at Kennedy's HHS. MedCity News Senior Reporter Frank Vinluan reached out to Pfizer and other vaccine makers to comment on this issue, and the response has been radio silence — which is interesting considering Bourla's earlier comments.

Sponsored What Are the Best Medical Coding Outsourcing Companies? Presented by Global Healthcare Resource Outsourcing your medical coding can help ensure a healthy revenue cycle. Discover the best medical coding outsourcing companies and find the right one for you. Learn More

Resources

Debunked Episode 14: Is This a Good Time for a Digital Health IPO? Hinge Health is poised to go public, 23andMe has filed for bankruptcy, and the importance of data sharing are the focus of the latest episode of the Debunked podcast with MedCity News Editor-in-Chief Arundhati Parmar and Samir Batra, managing partner of Health Innovation Pitch. Listen now

MedCity News • PO Box 901 • New York, NY unsubscribe